Kazakhstan
Almaty, 050020, Kazakhstan
NCT Number: NCT05088512
To research for a genetic marker of bronchial asthma, a single nucleotide polymorphism (SNP) analysis of DNA obtained from the peripheral blood of patients with bronchial asthma and normal control will be performed.
Looking for future studies?
Notify Me5 year–65 year
All sexes
Observational
Almaty, 050020, Kazakhstan
Unrelated Kazaks subjects who have bronchial asthma were recruited in the current study. Genotyping for various SNP associated due to the linkage disequilibrium patterns is to be performed. Genotypes would be statistically compared between patients with bronchial asthma and normal control subjects free of bronchial asthma
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SNP analysis of the DNA obtained from peripheral blood sample
Time frame: 1 year
Using SNPsto identify candidate genes associate with bronchial asthma
Asfendiyarov Kazakh National Medical University
Other
Preventive and Personalized Medicine (2021-2023)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00246922
Asthma, Bronchial Asthma
Osaka, Japan
View Trial DetailsNCT00242307
Asthma, Bronchial Asthma
Osaka, Japan
View Trial DetailsNCT04613245
Asthma, Asthma Chronic
Cairo, Egypt
View Trial DetailsNCT06916273
Asthma, Bronchial Asthma
Nanchang, Jiangxi, China
View Trial Details